SH
Sejal Harit Palan
About Sejal Harit Palan
Data last updated:
Sejal Harit Palan is a Director at Aptus Pharma Limited (since 2025). The company operates in Trading. Aptus Pharma Limited reported revenue of ₹24.64 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Feb 2025 | 2010 | ₹24.64 Cr (FY 2025) | Active |
Board colleagues of Sejal Harit Palan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chetan Shantilal Lalseta | 02547012 | Aptus Pharma Limited | Director |
| Ghanshyam Vinubhai Pansuriya | Aptus Pharma Limited | Ceo | |
| Jyotiben Hasmukhbhai Chandarana | 10607059 | Aptus Pharma Limited | Director |
| Kapilbhai Hasmukhbhai Chandarana | Aptus Pharma Limited | Cfo | |
| Mohini Hardikbhai Gandhi | Aptus Pharma Limited | Company Secretary | |
| Riddhish Natwarlal Tanna | 03231612 | Aptus Pharma Limited | Director |
| Tejash Maheshchandra Hathi | 03151221 | Aptus Pharma Limited | Managing Director |
| Vikas Rambhai Jobanputra | 10921323 | Aptus Pharma Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sejal Harit Palan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sejal Harit Palan
Sejal Harit Palan currently holds 1 directorship: Aptus Pharma Limited (Director, since 06 Feb 2025, revenue ₹24.64 Cr (FY 2025)).
Sejal Harit Palan was first appointed on 06 Feb 2025 as Director at Aptus Pharma Limited.
The current boards of Sejal Harit Palan's companies include Chetan Shantilal Lalseta (Aptus Pharma Limited), Ghanshyam Vinubhai Pansuriya (Aptus Pharma Limited), Jyotiben Hasmukhbhai Chandarana (Aptus Pharma Limited), Kapilbhai Hasmukhbhai Chandarana (Aptus Pharma Limited), Mohini Hardikbhai Gandhi (Aptus Pharma Limited), Riddhish Natwarlal Tanna (Aptus Pharma Limited), among others.